BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:790@biocityturku.fi
DTSTART;TZID=Europe/Helsinki:20250616T140000
DTEND;TZID=Europe/Helsinki:20250616T150000
DTSTAMP:20250606T091806Z
URL:https://biocityturku.fi/events/inflames-guest-seminar-2/
SUMMARY:InFLAMES Guest Seminar
DESCRIPTION:16th June at 14:00-15:00\nOnsite event\nin Alhopuro Auditorium\
 , Medisiina D\n\nProf. Shimon Sakaguchi\, Osaka University\, Japan\nInduct
 ion of regulatory T cells for immune tolerance\, a synthetic immunology ap
 proach\n\nHost: Riitta Lahesmaa (rilahes@utu.fi)\n\nShimon Sakaguchi is a 
 Distinguished Professor at the World Premier International Research Initia
 tive (WPI)-Immunology Frontier Research Center (IFReC) at Osaka University
 \, Japan. He is an immunologist recognized for his work on the control of 
 immune responses. He is known particularly for his discovery of regulatory
  T cells\, an indispensable constituent of the immune system for the maint
 enance of immune self-tolerance and homeostasis. Sakaguchi obtained an M.D
 . in 1976 and a Ph.D. in 1982 from Kyoto University\, Japan\, where he was
  trained as a pathologist and immunologist. After performing postdoctoral 
 studies at Johns Hopkins University and Stanford University\, he served as
  an Assistant Professor in the Department of Immunology at the Scripps Res
 earch Institute. After returning to Japan he was a Professor and the Chair
 man of the Department of Experimental Pathology\, Institute for Frontier M
 edical Sciences Kyoto University and served as the Director of the Institu
 te for several years. In 2011\, his lab moved to Osaka University and he a
 ssumed the current position. He has received numerous prestigious internat
 ional awards. Sakaguchi is the Sigrid Jusélius Foundation Visiting Profes
 sor at the University of Turku.\n\nSakaguchi studies the molecular and cel
 lular mechanisms of immunological tolerance and immune regulation. He has 
 shown that a population of immunosuppressive T-lymphocytes\, designated re
 gulatory T cells\, are present in the immune system and its deficiency or 
 dysfunction is causative of a variety of immunological disorders including
  autoimmune diseases. He has investigated the molecular basis of regulator
 y T cell development and function. In addition\, Sakaguchi and his laborat
 ory have demonstrated that numerical expansion of regulatory T cells or st
 rengthening of their suppressive activity is capable of preventing and tre
 ating autoimmune diseases and also establishing stable tolerance to transp
 lanted organs\, while their reduction in number or suppressive activity is
  able to provoke effective immunity against cancer. Sakaguchi is currently
  investigating how regulatory T cells can be targeted in humans to control
  a variety of physiological and pathological immune responses in clinical 
 settings.\n\n&nbsp\;\n\nSelected recent publications \n\nOsaki M\, Sakaguc
 hi S. Soluble CTLA-4 regulates immune homeostasis and promotes resolution 
 of inflammation by suppressing type 1 but allowing type 2 immunity. Immuni
 ty. 58(4):889-908.e13\, 2025. doi: 10.1016/j.immuni.2025.03.004.\n\nChen K
 Y\, Kibayashi T\, Giguelay A\, Hata M\, Nakajima S\, Mikami N\, Takeshima 
 Y\, Ichiyama K\, Omiya R\, Ludwig LS\, Hattori K\, Sakaguchi S. Genome-wid
 e CRISPR screen in human T cells reveals regulators of FOXP3. Nature. Mar 
 26\, 2025. doi: 10.1038/s41586-025-08795-5.\n\nIchiyama K\, Long J\, Kobay
 ashi Y\, Horita Y\, Kinoshita T\, Nakamura Y\, Kominami C\, Georgopoulos K
 \, Sakaguchi S. Transcription factor Ikzf1 associates with Foxp3 to repres
 s gene expression in Treg cells and limit autoimmunity and anti-tumor immu
 nity.  Immunity. 57(9):2043-2060.e10\, 2024. doi: 10.1016/j.immuni.2024.0
 7.010. Epub 2024 Aug 6.\n\nTay C\, Tanaka A\, Sakaguchi S. Tumor-infiltrat
 ing regulatory T cells as targets of cancer immunotherapy.  Cancer Cell.
  41(3):450-465\, 2023. doi: 10.1016/j.ccell.2023.02.014.\n\nSakaguchi S. T
 aking regulatory T cells into medicine.  J Exp Med. 218(6):e20210831\, 20
 21. doi: 10.1084/jem.20210831.\n\nKawakami R\, Kitagawa Y\, Chen KY\, Arai
  M\, Ohara D\, Nakamura Y\, Yasuda K\, Osaki M\, Mikami N\, Lareau CA\, Wa
 tanabe H\, Kondoh G\, Hirota K\, Ohkura N\, Sakaguchi S. Distinct Foxp3 en
 hancer elements coordinate development\, maintenance\, and function of reg
 ulatory T cells.  Immunity. 54(5):947-961.e8\, 2021. doi: 10.1016/j.immu
 ni.2021.04.005.\n\nSakaguchi S\, Mikami N\, Wing JB\, Tanaka A\, Ichiyama 
 K\, Ohkura N. Regulatory T Cells and Human Disease. Annu Rev Immunol. 38:5
 41-566\, 2020. doi: 10.1146/annurev-immunol-042718-041717.
ATTACH;FMTTYPE=image/jpeg:https://biocityturku.fi/wp-content/uploads/Infla
 mesGuestSeminar3_.jpg
CATEGORIES:Other events
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:DAYLIGHT
DTSTART:20250330T040000
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR